William Campbell
Keine laufenden Positionen mehr
Profil
William Campbell served as Chairman at Kinexus Bioinformatics Corp.
and as Director & Chief Scientific Officer at Regenerex Pharma, Inc. He received his undergraduate degree from Concordia University in 1962 and his doctorate degree from the University of Montréal in 1971.
Ehemalige bekannte Positionen von William Campbell
| Unternehmen | Position | Ende |
|---|---|---|
Kinexus Bioinformatics Corp.
 Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada. | Vorsitzender | - |
| PEPTIDE TECHNOLOGIES INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von William Campbell
| Concordia University | Undergraduate Degree |
| University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PEPTIDE TECHNOLOGIES INC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kinexus Bioinformatics Corp.
Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada. | Technology Services |
